Table 4.
Incidence of overlapping CDR3 sequences.
| CDR3 (amino acid) | RE brain (%) | RE blood (%) | FCD/TSC blood (%) | Normal blood (%) |
|---|---|---|---|---|
| CASSLGTDTQYF | 36 | 64 | 71 | 99 |
| CASSLSTDTQYF | 29 | 50 | 57 | 100 |
| CASSLGETQYF | 29 | 93 | 79 | 100 |
| CASSLGGTEAFF | 21 | 71 | 64 | 100 |
| CASSSQETQYF | 21 | 57 | 79 | 100 |
| CASSLGYEQYF | 21 | 79 | 79 | 99 |
| CASSPGYEQYF | 21 | 29 | 64 | 92 |
| CASSLGQNTEAFF | 21 | 86 | 64 | 100 |
| CASSIQGNTEAFF | 21 | 7 | 21 | 69 |
| CASSPLGSSYNEQFF | 21 | 0 | 7 | 46 |
| CASSLGQGNTGELFF | 21 | 36 | 36 | 83 |
| CASSPRDSYEQYF | 21 | 21 | 29 | 68 |
| CASRLGGGTEAFF | 21 | 0 | 14 | 19 |
| CASSFYNEQFF | 21 | 29 | 29 | 92 |
| CASSPNTEAFF | 21 | 50 | 57 | 93 |
| CASSPSGSSYEQYF | 21 | 29 | 7 | 73 |
| CASSLAGGTDTQYF | 21 | 57 | 71 | 99 |
| CASSSAYEQYF | 21 | 36 | 64 | 96 |
CDR3, third complementarity region; RE, Rasmussen encephalitis; FCD, focal cortical dysplasia; TSC, tuberous sclerosis complex.